APA (7th ed.) Citation

H, M., Z, Z., N, J., W, L., L, C., Q, S., & F, L. (2026). IL3RA identified as novel biomarker and therapeutic target for ER+ breast cancer through plasma proteome-wide mendelian randomization and TCGA database analysis. Clinical proteomics, 23(1), . https://doi.org/10.1186/s12014-026-09594-4

Chicago Style (17th ed.) Citation

H, Mei, Zhang Z, Jiang N, Lu W, Chang L, Song Q, and Li F. "IL3RA Identified as Novel Biomarker and Therapeutic Target for ER+ Breast Cancer Through Plasma Proteome-wide Mendelian Randomization and TCGA Database Analysis." Clinical Proteomics 23, no. 1 (2026). https://doi.org/10.1186/s12014-026-09594-4.

MLA (9th ed.) Citation

H, Mei, et al. "IL3RA Identified as Novel Biomarker and Therapeutic Target for ER+ Breast Cancer Through Plasma Proteome-wide Mendelian Randomization and TCGA Database Analysis." Clinical Proteomics, vol. 23, no. 1, 2026, https://doi.org/10.1186/s12014-026-09594-4.